Page 5 - Pierre Caloz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pierre caloz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pierre Caloz Today - Breaking & Trending Today

Brokers Offer Predictions for uniQure's FY2023 Earnings (NASDAQ:QURE)

UniQure (NASDAQ:QURE – Free Report) – Stock analysts at Chardan Capital issued their FY2023 EPS estimates for shares of uniQure in a report issued on Monday, July 10th. Chardan Capital analyst M. Barcus expects that the biotechnology company will post earnings of $4.19 per share for the year. Chardan Capital currently has a “Buy” rating […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Pierre Caloz , Christian Klemt , Exchange Traded Concepts , Wells Fargo Company , Securities Exchange Commission , Mitsubishi Ufj , Kokusai Asset Management Co , Financial Services Group Inc , Free Report , Chardan Capital , Wells Fargo , Qure Stock Down , Get Free Report , Exchange Commission , State Retirement System , Asset Management , Traded Concepts , Services Group , Kantonalbank Zurich Cantonalbank , Qure Daily ,

uniQure (NASDAQ:QURE) COO Sells $171,729.12 in Stock

uniQure (NASDAQ:QURE) COO Sells $171,729.12 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , Pierre Caloz , Kokusai Asset Management Co , Financial Services Group Inc , Qure Company Profile , Wells Fargo Company , Mitsubishi Ufj , Exchange Traded Concepts , Get Free Report , Qure Price , State Retirement System , Asset Management , Traded Concepts , Services Group , Kantonalbank Zurich Cantonalbank , Qure Company , Qure Daily ,

uniQure (NASDAQ:QURE) Downgraded to Sell at StockNews.com

StockNews.com downgraded shares of uniQure (NASDAQ:QURE – Free Report) from a hold rating to a sell rating in a report released on Friday. QURE has been the topic of a number of other reports. Guggenheim dropped their price target on uniQure from $53.00 to $46.00 in a research note on Friday, June 23rd. Chardan Capital […] ....

Christian Klemt , Pierre Caloz , Wells Fargo Company , Qure Company Profile , Silverarc Capital Management , Managers Group , Financial Services Group Inc , Covestor Ltd , Securities Exchange Commission , Free Report , Truist Financial , Moderate Buy , Get Free Report , Exchange Commission , Financial Advisors , Services Group , Qure Company , Qure Daily ,

uniQure (NASDAQ:QURE) Given New $14.00 Price Target at Wells Fargo & Company

UniQure (NASDAQ:QURE – Get Rating) had its target price cut by Wells Fargo & Company from $24.00 to $14.00 in a research report released on Thursday morning, The Fly reports. QURE has been the topic of a number of other research reports. UBS Group lowered their target price on uniQure from $45.00 to $42.00 in […] ....

Pierre Caloz , Rachelle Suzanne Jacques , Wells Fargo Company , Silvercrest Asset Management Group , First Trust Advisors , Jpmorgan Chase Co , Qure Company Profile , Securities Exchange Commission , Get Rating , Wells Fargo , Moderate Buy , Director Rachelle Suzanne Jacques , Exchange Commission , Bay Capital Management , Asset Management Group , Street Corp , Trust Advisors , Qure Company , Qure Daily , Nasdaq Qure , Lower Price Target ,

uniQure (QURE) Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event

uniQure (QURE) Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development Event
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Ricardo Dolmetsch , Ellen Bubrick , Pierre Caloz , Advances In Manufacturing Platform Technology , Neurology At Harvard Medical School , Epilepsy Surgery Program At Brigham , Wall Street , Harvard Medical School , Epilepsy Surgery Program , Temporal Lobe Epilepsy , Manufacturing Platform Technology , Temporal Lobe Epilepsytemporal ,